BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22388003)

  • 1. Advances in oral drug delivery: improved bioavailability of poorly absorbed drugs by tissue and cellular optimization. Preface.
    Morishita M; Peppas NA
    Adv Drug Deliv Rev; 2012 May; 64(6):479. PubMed ID: 22388003
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
    Porter CJ; Trevaskis NL; Charman WN
    Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse approaches for the enhancement of oral drug bioavailability.
    Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
    Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.
    Chakraborty S; Shukla D; Mishra B; Singh S
    Eur J Pharm Biopharm; 2009 Sep; 73(1):1-15. PubMed ID: 19505572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.
    Kawakami K
    Adv Drug Deliv Rev; 2012 May; 64(6):480-95. PubMed ID: 22265844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral colon delivery of insulin with the aid of functional adjuvants.
    Maroni A; Zema L; Del Curto MD; Foppoli A; Gazzaniga A
    Adv Drug Deliv Rev; 2012 May; 64(6):540-56. PubMed ID: 22086142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.
    Kohli K; Chopra S; Dhar D; Arora S; Khar RK
    Drug Discov Today; 2010 Nov; 15(21-22):958-65. PubMed ID: 20727418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment.
    Meng J; Hu L
    J Pharm Pharmacol; 2011 Mar; 63(3):400-8. PubMed ID: 21749388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.
    He CX; He ZG; Gao JQ
    Expert Opin Drug Deliv; 2010 Apr; 7(4):445-60. PubMed ID: 20201713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
    Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
    Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
    Porter CJ; Pouton CW; Cuine JF; Charman WN
    Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery to the small intestine.
    Friend DR
    Curr Gastroenterol Rep; 2004 Oct; 6(5):371-6. PubMed ID: 15341712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric micelles for oral drug delivery.
    Gaucher G; Satturwar P; Jones MC; Furtos A; Leroux JC
    Eur J Pharm Biopharm; 2010 Oct; 76(2):147-58. PubMed ID: 20600891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
    Grove M; Müllertz A; Nielsen JL; Pedersen GP
    Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral peptide delivery: improving the systemic availability of small peptides and enkephalin analogs.
    Lee HJ; Amidon GL
    NIDA Res Monogr; 1995; 154():86-106. PubMed ID: 8606751
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of administration site in the gastrointestinal tract on bioavailability of poorly absorbed drugs taken after a meal.
    Sakuma S; Tanno FK; Masaoka Y; Kataoka M; Kozaki T; Kamaguchi R; Kokubo H; Yamashita S
    J Control Release; 2007 Mar; 118(1):59-64. PubMed ID: 17250919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A timely reassessment of early prediction in the bioavailability of orally administered drugs.
    Larsen T; Link A
    Angew Chem Int Ed Engl; 2005 Jul; 44(29):4432-4. PubMed ID: 15984039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.